Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development
August 04, 2026
August 04, 2026
WASHINGTON, Aug. 4 [Category: BizLaw/Legal] -- WilmerHale, a law firm, posted the following news:
* * *
Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development
*
Ratio Therapeutics, Inc. (Ratio), a clinical-stage pharmaceutical company developing best-in-class radiopharmaceuticals for cancer treatment, announced the closing of a $70 million Series C financing. The financing included participation from existing i . . .
* * *
Ratio Therapeutics Closes $70 Million Series C Financing to Advance Clinical Development
*
Ratio Therapeutics, Inc. (Ratio), a clinical-stage pharmaceutical company developing best-in-class radiopharmaceuticals for cancer treatment, announced the closing of a $70 million Series C financing. The financing included participation from existing i . . .